Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure

Pharmacological Research

Volumn 73, Issue , 2013, Pages 35-43

  Sciorati, Clara ^a   Staszewsky, Lidia ^b   Zambelli, Vanessa ^c   Russo, Ilaria ^b   Salio, Monica ^b   Novelli, Deborah ^b   Di Grigoli, Giuseppe ^a,c,d   Moresco, Rosa Maria ^a,c,d   Clementi, Emilio ^e,f   Latini, Roberto ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Heart; Nitric oxide; Non steroidal anti inflammatory drugs; Skeletal muscle dystrophy

Indexed keywords

COLLAGEN; GLUCOSE; IBUPROFEN; ISOSORBIDE DINITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE METABOLISM; HEART STRESS; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIAC OUTPUT; IBUPROFEN; ISOSORBIDE DINITRATE; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; NITRIC OXIDE DONORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84878408547     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.04.009     Document Type: Article

References (58)

1. A.E. Emery The muscular dystrophies Lancet 359 2002 687 695
2. J. Finstererand, and C. Stollberger The heart in human dystrophinopathies Cardiology 99 2003 1 19
3. K. Miyoshi Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy British Heart Journal 66 1991 452 455
4. G. Nigro, L.I. Comi, L. Politano, and R.J. Bain The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy International Journal of Cardiology 26 1990 271 277
5. K. Bushby, F. Muntoni, and J.P. Bourke 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands Neuromuscular Disorders 13 2003 166 172
6. R.J. Fairclough, K.J. Perkins, and K.E. Davies Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy Current Gene Therapy 12 2012 206 244
7. T.A. Partridge Impending therapies for Duchenne muscular dystrophy Current Opinion in Neurology 24 2011 415 422
8. R.J. Fairclough, A. Bareja, and K.E. Davies Progress in therapy for Duchenne muscular dystrophy Experimental Physiology 96 2011 1101 1113
9. F.S. Tedesco, A. Dellavalle, J. Diaz-Manera, G. Messina, and G. Cossu Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells Journal of Clinical Investigation 120 2010 11 19
10. B. Palmieri, J.P. Tremblay, and L. Daniele Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy Pediatric Transplantation 14 2010 813 819
11. H.D. Allen, P.T. Thrush, T.M. Hoffman, K.M. Flanigan, and J.R. Mendell Cardiac management in neuromuscular diseases Physical Medicine and Rehabilitation Clinics of North America 23 2012 855 868
12. A. Malerba, L. Boldrin, and G. Dickson Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity Nucleic Acid Therapeutics 21 2011 293 298
13. D. Townsend, S. Yasuda, J. Chamberlain, and J.M. Metzger Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy Trends in Cardiovascular Medicine 19 2009 50 55
14. L.R. Bridges The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice Journal of the Neurological Sciences 72 1986 147 157
15. J.G. Quinlan, H.S. Hahn, B.L. Wong, J.N. Lorenz, A.S. Wenisch, and L.S. Levin Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings Neuromuscular Disorders 14 2004 491 496
16. M. Wehling-Henricks, M.C. Jordan, K.P. Roos, B. Deng, and J.G. Tidball Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium Human Molecular Genetics 14 2005 1921 1933
17. C.M. Adamo, D.F. Dai, J.M. Percival, E. Minami, M.S. Willis, and E. Patrucco Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy Proceedings of the National Academy of Sciences of the United States of America 107 2010 19079 19083
18. S. Chowdharyand, and J.N. Townend Role of nitric oxide in the regulation of cardiovascular autonomic control Clinical Science (London) 97 1999 5 17
19. B. Bostick, Y. Yue, C. Long, and D. Duan Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression Circulation Research 102 2008 121 130
20. B.L. Bia, P.J. Cassidy, M.E. Young, J.A. Rafael, B. Leighton, and K.E. Davies Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy Journal of Molecular and Cellular Cardiology 31 1999 1857 1862
21. M. Khairallah, R.J. Khairallah, M.E. Young, B.G. Allen, M.A. Gillis, and G. Danialou Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency Proceedings of the National Academy of Sciences of the United States of America 105 2008 7028 7033
22. M. Khairallah, R. Khairallah, M.E. Young, J.R. Dyck, B.J. Petrof, and C. Des Rosiers Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy Journal of Molecular and Cellular Cardiology 43 2007 119 129
23. R.J. Khairallah, M. Khairallah, R. Gelinas, B. Bouchard, M.E. Young, and B.G. Allen Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation Journal of Molecular and Cellular Cardiology 45 2008 230 239
24. M. Wehling-Henricks, M.C. Jordan, T. Gotoh, W.W. Grody, K.P. Roos, and J.G. Tidball Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy PLoS ONE 5 2010 e10763
25. S. Brunelli, C. Sciorati, G. D'Antona, A. Innocenzi, D. Covarello, and B.G. Galvez Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy Proceedings of the National Academy of Sciences of the United States of America 104 2007 264 269
26. M.G. D'Angelo, S. Gandossini, F. Martinelli Boneschi, C. Sciorati, S. Bonato, and E. Brighina Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients Pharmacological Research 65 2012 472 479
27. C. Sciorati, R. Buono, E. Azzoni, S. Casati, P. Ciuffreda, and G. D'Angelo Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans British Journal of Pharmacology 160 2010 1550 1560
28. C. Sciorati, D. Miglietta, R. Buono, V. Pisa, D. Cattaneo, and E. Azzoni A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy Pharmacological Research 64 2011 210 217
29. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification European Journal of Echocardiography 7 2006 79 108
30. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms Journal of the American Society of Echocardiography 2 1989 358 367
31. F. Fiordaliso, S. Chimenti, L. Staszewsky, A. Bai, E. Carlo, and I. Cuccovillo A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury Proceedings of the National Academy of Sciences of the United States of America 102 2005 2046 2051
32. A.J. Burger, M.P. Notarianni, and D. Aronson Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease American Journal of Cardiology 86 2000 825 829
33. L.C. Junqueira, G. Bignolas, and R.R. Brentani Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections Histochemical Journal 11 1979 447 455
34. C. Zoja, S. Cattaneo, F. Fiordaliso, V. Lionetti, V. Zambelli, and M. Salio Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes American Journal of Physiology. Renal Physiology 301 2011 F1114 F1123
35. P. Anversa, C. Beghi, Y. Kikkawa, and G. Olivetti Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy American Journal of Pathology 118 1985 484 492
36. D.I. Simon, Z. Dhen, P. Seifert, E.R. Edelman, C.M. Ballantyne, and C. Rogers Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty Journal of Clinical Investigation 105 2000 293 300
37. V. Zambelli, G. Di Grigoli, M. Scanziani, S. Valtorta, M. Amigoni, and S. Belloli Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury Intensive Care Medicine 38 2012 694 701
38. J.K. Perloff, E. Henze, and H.R. Schelbert Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging Circulation 69 1984 33 42
39. M. Sampaolesi, S. Blot, G. D'Antona, N. Granger, R. Tonlorenzi, and A. Innocenzi Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs Nature 444 2006 574 579
40. P. Gregorevic, M.J. Blankinship, J.M. Allen, R.W. Crawford, L. Meuse, and D.G. Miller Systemic delivery of genes to striated muscles using adeno-associated viral vectors Nature Medicine 10 2004 828 834
41. S. Wilton PTC124, nonsense mutations and Duchenne muscular dystrophy Neuromuscular Disorders 17 2007 719 720
42. D. Townsend, S. Yasuda, S. Li, J.S. Chamberlain, and J.M. Metzger Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle Molecular Therapy 16 2008 832 835
43. N.D. Roeand, and J. Ren Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases Vascular Pharmacology 57 2012 168 172
44. G. Lim, L. Venetucci, D.A. Eisner, and B. Casadei Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling Cardiovascular Research 77 2008 256 264
45. A.L. Taylor Nitric oxide modulation as a therapeutic strategy in heart failure Heart Failure Clinics 8 2012 255 272
46. V. Kapil, A.J. Webb, and A. Ahluwalia Inorganic nitrate and the cardiovascular system Heart 96 2010 1703 1709
47. J. Gilroy, J.L. Cahalan, R. Berman, and M. Newman Cardiac and pulmonary complications in Duchenne's progressive muscular dystrophy Circulation 27 1963 484 493
48. S.K. Sanyal, W.W. Johnson, M.K. Thapar, and S.E. Pitner An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy Circulation 57 1978 1122 1129
49. Y.J. Cheng, D. Lang, S.D. Caruthers, I.R. Efimov, J. Chen, and S.A. Wickline Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts American Journal of Physiology. Heart and Circulatory Physiology 303 2012 H559 H568
50. N. Jearawiriyapaisarn, H.M. Moulton, P. Sazani, R. Kole, and M.S. Willis Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers Cardiovascular Research 85 2009 444 453
51. D.S. Bredt NO skeletal muscle derived relaxing factor in Duchenne muscular dystrophy Proceedings of the National Academy of Sciences of the United States of America 95 1998 14592 14593
52. G. Bosser, H. Lucron, J.P. Lethor, G. Burger, F. Beltramo, and P.Y. Marie Evidence of early impairments in both right and left ventricular inotropic reserves in children with Duchenne's muscular dystrophy American Journal of Cardiology 93 2004 724 727
53. Y. Burelle, M. Khairallah, A. Ascah, B.G. Allen, C.F. Deschepper, and B.J. Petrof Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart Journal of Molecular and Cellular Cardiology 48 2009 310 321
54. J.S. Ingwall Energy metabolism in heart failure and remodelling Cardiovascular Research 81 2009 412 419
55. H. Ashrafianand, and M.P. Frenneaux Metabolic modulation in heart failure: the coming of age Cardiovascular Drugs and Therapy 21 2007 5 7
56. W. Zhang, M. ten Hove, J.E. Schneider, D.J. Stuckey, L. Sebag-Montefiore, and B.L. Bia Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study Journal of Molecular and Cellular Cardiology 45 2008 754 760
57. A. Ascah, M. Khairallah, F. Daussin, C. Bourcier-Lucas, R. Godin, and B.G. Allen Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil American Journal of Physiology. Heart and Circulatory Physiology 300 2010 H144-153
58. G.M. Buyse, G. Van der Mieren, M. Erb, J. D'Hooge, P. Herijgers, and E. Verbeken Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance European Heart Journal 30 2009 116 124